Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 2
Submit an article Journal homepage
10
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The Management of Stage I-II Supradiaphragmatic Hodgkin's Disease with Chemotherapy Alone

Mariano Provencio Department of Oncology and Biostatistics, Hospital Universitario "Clínica Puerta de Hierro", Madrid, Spain
,
Pilar España Department of Oncology and Biostatistics, Hospital Universitario "Clínica Puerta de Hierro", Madrid, Spain
,
Isabel Millán Department of Oncology and Biostatistics, Hospital Universitario "Clínica Puerta de Hierro", Madrid, Spain
,
Antonio Sánchez Department of Oncology and Biostatistics, Hospital Universitario "Clínica Puerta de Hierro", Madrid, Spain
,
Blanca Cantos Department of Oncology and Biostatistics, Hospital Universitario "Clínica Puerta de Hierro", Madrid, Spain
&
Félix Bonilla Department of Oncology and Biostatistics, Hospital Universitario "Clínica Puerta de Hierro", Madrid, Spain
Pages 263-268 | Published online: 01 Jul 2009

  • Sieber. M., Engert, A. and Diehl, V. (2000) "Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group", Ann. Oncol. ll(Suppl, 1), S81-S85.
  • Longo, D.L., Glastein, E., Duffey, P.L., Young, R.C., Hubbard, S.M., Urba, W.J., et al. (1991) "Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease seven years results of a prospective clinical trial", J. Clin. Oncol., 906-917.
  • Biti, G.P., Cimino, G., Cartoni, C., Magrini, S.M., Anselmo, A.P., Enrici, R.M., et al. (1992) "Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I. IIA Hodgkin's disease: eight-year update of an Italian prospective randomised study". J. Clin. Oncol. 10, 378-382.
  • Carbone, P.P., Kaplan, H.S., Musshoff. K., Smithers, D.W. and Tubiana, M. (1971) "Report of the committee on Hodgkin's disease staging classification", Cancer Res. 31, 1860-1861.
  • Lister, T.A., Crowther, D., Sutcliffe, S.B., Canellos, G.P., Young, R.C., Rosemberg, S.A., et al. (1989) "Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting", J. Clin. Oncol. 7, 1630-1636.
  • De Vita, V.T. and Serpick, A. (1967) "Combination chemotherapy in the treatment of advanced Hodgkin's disease (abstract)", Proc. Am. Assoc. Cancer Res. 8, 13.
  • Bonadonna, G., Zucali, R., Monfardini, S., De Lena, M. and Uslunghi, C. (1975) "Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP", Cancer 36, 252-259.
  • Bonadonna, G., Valagussa, P. and Santoro, A. (1986) "Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease". Ann. lntern. Med. 104, 739-746.
  • Urba, W.J. and Longo, D. (1992) "Hodgkin's disease", N. Engl. J. Med. 10, 678-687.
  • Kaplan, E.L. and Meier, P. (1958) "Non-parametric estimation from incomplete observations". J. Am. Stat. Assoc. 53, 457-481.
  • Hasenclever, D. and Diehl, V. (1998) "A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's disease". N. Engl. J. Med. 339, 1506.
  • Mauch, P., Tarbell, N., Weinstein, H., Silver, B., Goffman, T., Osteen, R., et al. (1988) "Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and para-aortic irradiation". J. Clin. Oncol. 6, 1576-1583.
  • Leopold, K., Canellos, G., Rosenhahl, D., Shulman, L.N., Weinstein, M. and Mauch, P. (1989) "Stage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy". J. Clin. Oncol. 7, 1059-1065.
  • Leibenhaut, M., Hoppe, R., Efron, B., Halpern, J., Nelsen, T. and Rosemberg, S.A. (1989) "Prognostic indicators of Iaparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease". J. Clin. Oncol. 7, 81-91.
  • Mauch, P., Larson, D., Osteen, R., Silver, B., Yeap, B., Canellos, G., et al. (1990) "Prognostic factors for positive surgical staging in patients with Hodgkin's disease". J. Clin. Oncol. 8, 257-265.
  • Hoppe, R., Coleman, C., Cox, R.S., Rosemberg, S.A. and Kaplan, H.S. (1982) "The management of stage I--Il Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience", Blood 59, 455-465.
  • Specht. L., Carde, P., Mauch, R., Magrini, S.M. and Santarelli, M.T. (1992) "Radiotherapy versus combined modality in early stages Hodgkin's disease". Ann. Oncol. 3, 77-81.
  • Cmkovich, M., Leopold, K., Hoppe, R. and Mauch, P.M. (1987) "Stage I to IIB Hodgkin' disease: the combined experience at Stanford University and the joint center for radiation therapy". J. Clin. Oncol. 5, 1041-1049.
  • Fuller, L., Madoc-Jones, H., Shullenberg, C., Hagemeister, F.B., Rodgers, R.W., North, L.B., et al. (1980) "Further follow-up of results of treatment in 90 laparotomy-negative stage I and Il Hodgkin's disease patients: significance of mediastinal and nonmediastinal presentations". Int. J. Radicat. Oncol. Biol. Phys.6, 799-808.
  • Ziltoun, R., Audebert, T.A., Hoemi, B., Bernadou, A., Kirulik, M., Rojovan, J., et al. (1985) "Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease". J. Clin. Oncol. 3, 207-214.
  • Schomberg, R. Evans, R., O'Connell, M., White, W.L., Banks, P.M., Ustrup, D.M., et al. (1984) "Prognostic significance of mediastinal mass in adult Hodgkin's disease", Cancer 53, 324-328.
  • Cosset, J.M., Henry Amar, M., Meerwaldt, J.H., Carde, P., Noordijk, E.M., Thomas, J., et al. (1992) "The EORTC trials for limited stage Hodgkin's disease". Cancer 28A, 1847-1850.
  • Cosset, J.M. and Mauch, P.M. (1998) "The role of radiotherapy for early stage Hodgkin's disease: limitations and perspectives", Ann. Oncol. 9(Suppl. 5), S57-S62.
  • Loeffler, M., Dielh, V., Pfreundschuh, M., Ruhl, U., Hasenclever, D., Nisters-Backes, H., et al. (1997) "Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease". J. Clin. Oncol. 15, 2275-2287.
  • Noordijk, R. Carde, P., Hagenbeek, A., Burgers, J.M.V., Tirelli, U., Moncondvit, M., et al. (1997) "Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I-II Hodgkin's disease, Six-year results of the EORTC-GPMC controlled clinical trials H7-VF, H7-F, and H7-U (abst)". Int. J. Radiat. Oncol. Biol. Phys. 39, 173.
  • Petera, J., Macharova, H., Pohankova, R., Malir, A., Coupek, P., Konecny, M., et al. (2000) "Radiotherapy of early stages Hodgkin's disease, 10 years experience of the Masaryk Memorial Cancer Institute", Neoplasma 47, 129-132.
  • Specht, L., Gray, R.G., Clarke, M.J. and Peto, R. (1998) "Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a Meta-analysis of 23 randomised trials involving 3,888 patients". J. Clin. Oncol. 16, 830-843.
  • Gobbi, P.G., Pieresca, C., Frassoldati, A., Curotenuto, M., Di Renzo, N., La Sala, A., et al. (1996) "Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favourably presenting, clinically staged Hodgkin's patients: the Gruppo italiano per Io Studio dei Linfomi Experience". J. Clin. Oncol. 14(2), 527-533.
  • Yaniv, I., Saab, A., Cohen, I.J., Goshen, Y., Loven, D., Stark, B., et al. (1996) "Hodgkin disease in children: reducted tailored chemotherapy for stage I- II disease". J. Pediatr. Hematol. Oncol. 18, 76-80.
  • Colonna, P., Jais, J., Desablens, B., Harousseau, J.L., Briere, J., Boasson, M., et al. (1996) "Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Quest-France 81/12 trial, including 262 patients". J. Clin. Oncol. 14, 1928-1935.
  • Rueda, A., Alba, E., Ribelles, N., Sevilla, I., Ruiz, I. and Miramon, J. (1997) "Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study". J Clin. Oncol. 15, 118-122.
  • Báez, F., Ocampo, E., Conter, V., Flores, A., Gutiérrez, T., Malta, A., et al. (1997) 'Treatment of childhood Hodgkin's disease with COPP or COPP_ABV (hybrid) without radiotherapy in Nicaragua". Ann. Oncol. 8(3), 247-250.
  • Horning, S., Hoppe, R., Mason, J., Brown, B.W., Hancock, S.L., Baer, D., et al. (1997) "Permanente Gl study for clinical stage 1 to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation". J. Clin. Oncol. 15, 1736-1744.
  • Ruiz-Arguelles, G.J., Gomez-Almaguer, D. and Apreza-Molina, M.G. (1997) "Chemotherapy alone may be an efficient alternative in the treatment of early stage Hodgkin's disease if optimal radiotherapy is not available", Leuk. Lemphoma 27, 179-183.
  • Tormo, M., Terol, M.J., Marugan, I., Solano, C., Benet, I. and Garcia-Conde, J. (1999) "Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vinblastine, vincristine, prednisone) and radiotherapy", Leuk. Lymphoma 34, 137-142.
  • Wasserman, T.H., Petroni, G.R., Millard, F.F., Chug, C.T., Barcos, M., Johnson, J.L., et al. (1999) "Sequential chemotherapy (etoposide, vinblastine and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: a phase Il Cancer and Leukemia Group B Study (9051)". Cancer 15, 1590-1595.
  • Angelopoulou, M.K., Vassilakopoulos, T.P., Siakantaris, M.P., Kontopidou, F.N., Boussiotis, V.A., Papavassiliou, C.,. et al. (2000) "EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease". Leuk Lymphoma 37, 131-143.
  • Landman-Parker, J., Pacquement, H., Leblanc, T., Hahrand, J.L., Terrier-Lacombe, M.J., Bertrand, Y., et al., (2000) "Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90", J. Clin. Oncol. 18, 1500-1507.
  • Brusamolino, E., Lunghi, F., Orlandi, E., Astori, C., Passamonti, F., Barate, C., et al. (2000) "Treatment of early-stage Hodgkin's disease with tour cycles to ABVD followed by adjuvant radiotherapy: analysis of efficacy and long-term toxicity". Haematologica 85, 1032-1039.
  • Swerdlow, A.J., Barber, J.A., Horwich, A., Cunningham, D., Milan, S. and Omar, R.Z. (1997) "Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital", Br. J. Cancer 75, 116-123.
  • Mauch, P., Kalish, L., Marcus, K., Coleman, C.N., Shulman, L.N., Krill, E., et al. (1996) "Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: 20-year analysis of risk factors and outcome". Blood 87, 3625-3632.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.